Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients

Authors: C. Grégoire, H. Nicolas, I. Bragard, F. Delevallez, I. Merckaert, D. Razavi, D. Waltregny, M.-E. Faymonville, A. Vanhaudenhuyse

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Prostate and breast cancer can have a lot of negative consequences such as fatigue, sleep difficulties and emotional distress, which decrease quality of life. Group interventions showed benefits to emotional distress and fatigue, but most of these studies focus on breast cancer patients. However, it is important to test if an effective intervention for breast cancer patients could also have benefits for prostate cancer patients.

Methods

Our controlled study aimed to compare the efficacy of a self-hypnosis/self-care group intervention to improve emotional distress, sleep difficulties, fatigue and quality of life of breast and prostate cancer patients. 25 men with prostate cancer and 68 women with breast cancer participated and were evaluated before (T0) and after (T1) the intervention.

Results

After the intervention, the breast cancer group showed positive effects for anxiety, depression, fatigue, sleep difficulties, and global health status, whereas there was no effect in the prostate cancer group. We showed that women suffered from higher difficulties prior to the intervention and that their oncological treatments were different in comparison to men.

Conclusion

The differences in the efficacy of the intervention could be explained by the baseline differences. As men in our sample reported few distress, fatigue or sleep problems, it is likely that they did not improve on these dimensions.

Trial registration

ClinicalTrials.​gov (NCT02569294 and NCT03423927). Retrospectively registered in October 2015 and February 2018 respectively.
Literature
1.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Kanso C, Etner J, Debré B, Zerbib M. Cancer de la prostate : aspects médicoéconomiques. Prog En Urol. 2012:85–90.
3.
Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, et al. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012;187:1259–65.CrossRefPubMed
4.
Kim HS, Freedland SJ. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management. Curr Opin Support Palliat Care. 2010;4:147–52.CrossRefPubMed
5.
Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009;53:171–84.CrossRefPubMed
6.
DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.CrossRefPubMed
7.
8.
McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19:508–16.CrossRefPubMed
9.
Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, et al. Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study. Int J Radiat Oncol Biol Phys. 2012;84:88–94.CrossRefPubMed
10.
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRefPubMed
11.
12.
Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ. The supportive care needs of men with advanced prostate Cancer. Oncol Nurs Forum. 2011;38:189–98.CrossRefPubMed
13.
14.
Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol Stockh Swed. 2011;50:187–93.CrossRef
15.
Fransson P. Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluation. J Cancer Res Ther. 2010;6:516–20.CrossRefPubMed
16.
Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, et al. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34:171–9.CrossRefPubMedPubMedCentral
17.
Selli C, Bjartell A, Burgos J, Somerville M, Palacios J-M, Benjamin L, et al. Burden of illness in prostate Cancer patients with a low-to-moderate risk of progression: a one-year, pan-European observational study. Prostate Cancer. 2014;2014:e472949.CrossRef
18.
19.
Gonzalez BD, Jim HSL, Booth-Jones M, Small BJ, Sutton SK, Lin H-Y, et al. Course and predictors of cognitive function in patients with prostate Cancer receiving androgen-deprivation therapy: a controlled comparison. J Clin Oncol. 2015;33:2021–7.CrossRefPubMedPubMedCentral
20.
Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38:926–34.CrossRefPubMed
21.
Jim HSL, Phillips KM, Chait S, Faul LA, Popa MA, Lee Y-H, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3578–87.CrossRef
22.
23.
McGinty HL, Phillips KM, Jim HSL, Cessna JM, Asvat Y, Cases MG, et al. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer. 2014;22:2271–80.CrossRefPubMedPubMedCentral
24.
Wu L, Tanenbaum ML, Dijkers MPJM, Amidi A, Hall SJ, Penedo FJ, et al. Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: a mixed methods study. Soc Sci Med. 2016;156:80–9.
25.
Hernández Blázquez M, Cruzado JA. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy. J Psychosom Res. 2016;87:14–21.CrossRefPubMed
26.
Jayadevappa R, Malkowicz SB, Chhatre S, Johnson JC, Gallo JJ. The burden of depression in prostate cancer. Psychooncology. 2012;21:1338–45.CrossRefPubMed
27.
Thornton AA, Perez MA, Oh S, Crocitto L. A prospective report of changes in prostate cancer related quality of life after robotic prostatectomy. J Psychosoc Oncol. 2011;29:157–67.CrossRefPubMed
28.
Tojal C, Costa R. Depressive symptoms and mental adjustment in women with breast cancer. Psychooncology. 2015;24:1060–5.CrossRefPubMed
29.
Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4:e003901.CrossRefPubMedPubMedCentral
30.
Lindbohm M-L, Kuosma E, Taskila T, Hietanen P, Carlsen K, Gudbergsson S, et al. Cancer as the cause of changes in work situation (a NOCWO study). Psychooncology. 2011;20:805–12.CrossRefPubMed
31.
Lindbohm M-L, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv Res Pract. 2012;6:72–81.CrossRef
32.
Sharp L, Timmons A. Social welfare and legal constraints associated with work among breast and prostate cancer survivors: experiences from Ireland. J Cancer Surviv Res Pract. 2011;5:382–94.CrossRef
33.
Chung E, Brock G. Sexual rehabilitation and Cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate Cancer survivors. J Sex Med. 2013;10:102–11.CrossRefPubMed
34.
Donovan KA, Walker LM, Wassersug RJ, Thompson LMA, Robinson JW. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners. Cancer. 2015;121:4286–99.CrossRefPubMed
35.
Howlett K, Koetters T, Edrington J, West C, Paul S, Lee K, et al. Changes in sexual function on mood and quality of life in patients undergoing radiation therapy for prostate Cancer. Oncol Nurs Forum. 2009;37:E58–66.CrossRef
36.
Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.CrossRefPubMedPubMedCentral
37.
Ussher JM, Perz J, Hawkins Y, Brack M. Evaluating the efficacy of psycho-social interventions for informal carers of cancer patients: a systematic review of the research literature. Health Psychol Rev. 2009;3:85–107.CrossRef
38.
Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol. 2010;183:2206–12.CrossRefPubMedPubMedCentral
39.
Prabhu V, Sivarajan G, Taksler GB, Laze J, Lepor H. Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate Cancer. Eur Urol. 2014;65:52–7.CrossRefPubMed
40.
Karabulut N, Erci B. Sexual desire and satisfaction in sexual life affecting factors in breast cancer survivors after mastectomy. J Psychosoc Oncol. 2009;27:332–43.CrossRefPubMed
41.
Park HY, Kim JH, Choi S, Kang E, Oh S, Kim JY, et al. Psychological effects of a cosmetic education programme in patients with breast cancer. J Cancer Care. 2015;24:493–502.CrossRef
42.
Manne S, Badr H, Zaider T, Nelson C, Kissane D. Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv. 2010;4:74–85.CrossRefPubMed
43.
Northouse LL, Katapodi MC, Schafenacker AM, Weiss D. The impact of caregiving on the psychological well-being of family caregivers and Cancer patients. Semin Oncol Nurs. 2012;28:236–45.CrossRefPubMed
44.
Goldsmith DJ, Miller GA. Conceptualizing how couples talk about Cancer. Health Commun. 2014;29:51–63.CrossRefPubMed
45.
Martin E, Bulsara C, Battaglini C, Hands B, Naumann FL. Breast and prostate cancer survivor responses to group exercise and supportive group psychotherapy. J Psychosoc Oncol. 2015;33:620–34.CrossRefPubMed
46.
Mériaux E, Joly F. Cancer de la prostate : effets secondaires des traitements sur la masculinité (identité masculine, fertilité, sexualité). Psycho-Oncol. 2017;11:134–7.CrossRef
47.
Davis KM, Kelly SP, Luta G, Tomko C, Miller AB, Taylor KL. The Association of Long-term Treatment-related Side Effects with Cancer-specific and General Quality of life among prostate Cancer survivors. Urology. 2014;84:300–6.CrossRefPubMedPubMedCentral
48.
Holden AEC, Ramirez AG, Gallion K. Depressive symptoms in Latina breast cancer survivors: a barrier to cancer screening. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2014;33:242–8.
49.
Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10:51–61.CrossRefPubMed
50.
Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate Cancer. N Engl J Med. 2013;368:436–45.CrossRefPubMedPubMedCentral
51.
Taylor KL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, et al. Long-term disease-specific functioning among prostate Cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian Cancer screening trial. J Clin Oncol. 2012;30:2768–75.CrossRefPubMedPubMedCentral
52.
Grégoire C, Bragard I, Jerusalem G, Etienne A-M, Coucke P, Dupuis G, et al. Group interventions to reduce emotional distress and fatigue in breast cancer patients: a 9-month follow-up pragmatic trial. Br J Cancer. 2017;117(10):bjc2017326.
53.
Hammond DC. Hypnosis in the treatment of anxiety- and stress-related disorders. Expert Rev Neurother. 2010;10:263–73.CrossRefPubMed
54.
Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:782–93.CrossRef
55.
56.
Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, et al. Putting evidence into practice: an update of evidence-based interventions for Cancer-related fatigue during and following treatment. Clin J Oncol Nurs. 2014;18:38–58.CrossRefPubMed
57.
Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, et al. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast Cancer. J Clin Oncol. 2014;32:557–63.CrossRefPubMedPubMedCentral
58.
Cramer H, Lauche R, Paul A, Langhorst J, Kümmel S, Dobos GJ. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14:5–15.CrossRefPubMed
59.
Gudenkauf LM, Antoni MH, Stagl JM, Lechner SC, Jutagir DR, Bouchard LC, et al. Brief cognitive-behavioral and relaxation training interventions for breast cancer: a randomized controlled trial. J Consult Clin Psychol. 2015;83:677–88.CrossRefPubMedPubMedCentral
60.
Visser A, van Andel G. Psychosocial and educational aspects in prostate cancer patients. Patient Educ Couns. 2003;49:203–6.CrossRefPubMed
61.
Keogh JWL, MacLeod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate Cancer patients: a systematic review. J Pain Symptom Manag. 2012;43:96–110.CrossRef
62.
Chipperfield K, Brooker J, Fletcher J, Burney S. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: a systematic review. Health Psychol. 2014;33:1288–97.CrossRefPubMed
63.
Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate Cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014;32:335–46.CrossRefPubMed
64.
Larkin D, Lopez V, Aromataris E. Managing cancer-related fatigue in men with prostate cancer: a systematic review of non-pharmacological interventions. J Nurs Pract. 2014;20:549–60.CrossRef
65.
Chambers SK, Pinnock C, Lepore SJ, Hughes S, O’Connell DL. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns. 2011;85:e75–88.CrossRefPubMed
66.
Newby TA, Graff JN, Ganzini LK, McDonagh MS. Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis. Psychooncology. 2015;24:1686–93.CrossRefPubMed
67.
Bragard I, Etienne A-M, Faymonville M-E, Coucke P, Lifrange E, Schroeder H, et al. A non-randomized comparison study of self-hypnosis, yoga and cognitive behavioral therapy to reduce emotional distress in breast cancer patients. Int J Clin Exp Hypn. 2017 [cited 2017 Jan 13]; Available from: http://​orbi.​ulg.​ac.​be/​handle/​2268/​195981.
68.
Vanhaudenhuyse A, Gillet A, Malaise N, Salamun I, Barsics C, Grosdent S, et al. Efficacy and cost-effectiveness: a study of different treatment approaches in a tertiary pain Centre. Eur J Pain Lond Engl. 2015;19:1437–46.CrossRef
69.
Vanhaudenhuyse A, Gillet A, Malaise N, Salamun I, Grosdent S, Maquet D, et al. Psychological interventions influence patients’ attitudes and beliefs about their chronic pain. J Tradit Complement Med. 2017 [cited 2017 Nov 21]; Available from: http://​orbi.​ulg.​ac.​be/​handle/​2268/​207607.
70.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
71.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
72.
Savard M-H, Savard J, Simard S, Ivers H. Empirical validation of the insomnia severity index in cancer patients. Psychooncology. 2005;14:429–41.CrossRefPubMed
73.
Cohen J. Statistical power analysis for the behavioral sciences. Massachusetts: Academic Press; 1977.
74.
Nolen-Hoeksema S. Gender Differences in Depression. Curr Dir Psychol Sci. 2001;10:173–6.CrossRef
75.
Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141:343–51.CrossRefPubMed
76.
Bhattacharjee A, Banerjee A. State and trait anxiety among cancer patients: a comparative analysis. J Psychosoc Res. 2016;11:427–36.
77.
Stapleton SJ, Valerio TD, Astroth KS, Woodhouse S. Distress during radiation therapy: assessment among patients with breast or prostate cancer. J Oncol Nurs. 2017;21:93–8.CrossRef
78.
Tang Y, Yang W, Wang Y-L, Lin L. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2012;24:702–7.CrossRefPubMed
79.
Alosaimi FD, Al-Sultan OA, Alghamdi QA, Almohaimeed IK, Alqannas SI. Gender-specific differences in depression and anxiety symptoms and help-seeking behavior among gastroenterology patients in Riyadh, Saudi Arabia. Neurosci Riyadh Saudi Arab. 2014;19:203–9.
80.
McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45:1027–35.CrossRefPubMedPubMedCentral
81.
Mo PKH, Malik SH, Coulson NS. Gender differences in computer-mediated communication: a systematic literature review of online health-related support groups. Patient Educ Couns. 2009;75:16–24.CrossRefPubMed
82.
Nekolaichuk CL, Cumming C, Turner J, Yushchyshyn A, Sela R. Referral patterns and psychosocial distress in cancer patients accessing a psycho-oncology counseling service. Psychooncology. 2011;20:326–32.CrossRefPubMed
83.
Owen JE, Klapow JC, Roth DL, Tucker DC. Use of the internet for information and support: disclosure among persons with breast and prostate cancer. J Behav Med. 2004;27:491–505.CrossRefPubMed
84.
Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–26.CrossRef
85.
Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P. The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer. 2000;88:226–37.CrossRefPubMed
86.
Halbert CH, Wrenn G, Weathers B, Delmoor E, Ten Have T, Coyne JC. Sociocultural determinants of men’s reactions to prostate cancer diagnosis. Psychooncology. 2010;19:553–60.CrossRefPubMedPubMedCentral
87.
Helgason AR, Dickman PW, Adolfsson J, Steineck G. Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients. Scand J Urol Nephrol. 2001;35:97–101.CrossRefPubMed
88.
Clover KA, Mitchell AJ, Britton B, Carter G. Why do oncology outpatients who report emotional distress decline help? Psychooncology. 2015;24:812–8.CrossRefPubMed
89.
Blank TO, Schmidt SD, Vangsness SA, Monteiro AK, Santagata PV. Differences among breast and prostate cancer online support groups. Comput Hum Behav. 2010;26:1400–4.CrossRef
90.
Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:3830–42.CrossRef
Metadata
Title
Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients
Authors
C. Grégoire
H. Nicolas
I. Bragard
F. Delevallez
I. Merckaert
D. Razavi
D. Waltregny
M.-E. Faymonville
A. Vanhaudenhuyse
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4607-z

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Impact of viral presence in tumor on gene expression in non-small cell lung cancer

Research article

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma

Research article

Prognostic value of differentiation status in gastric cancer

Research article

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer

Research article

AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity

Case report

Synchronous anal canal carcinoma in a heterosexual couple
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits